logoTry Persana

Nephrogen - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Nephrogen including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Nephrogen company logo

Curative gene therapies for kidney diseases

Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.

HeadquartersNew York, United States
Team size1-10
Founded2022

What is Nephrogen? - Company Overview & Details

Nephrogen is Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure. Founded in 2022, the company is headquartered in New York, United States.

Who are the Key Executives at Nephrogen? - Leadership Team

Nephrogen is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Nephrogen

CEO

Chief Technology Officer (CTO) of Nephrogen

CTO

Nephrogen Company Details & Key Information

Where is Nephrogen located?

Nephrogen is headquartered in New York, United States.

How many employees does Nephrogen have?

Nephrogen has 1-10 employees.

When was Nephrogen founded?

Nephrogen was founded in 2022.

Nephrogen Official Website

How much funding has Nephrogen raised?

Nephrogen has raised undisclosed amount across 1 funding rounds. The most recent funding was completed on 2020-10-01.

Funding Overview

Nephrogen received non-equity assistance funding.

N/A
Total Funding Raised
1
Funding Rounds
2020-10-01
Latest Round

Nephrogen Funding History

Non equity assistance
2020-10-01

Who are the key investors in Nephrogen?

Investor Information Not Available

Detailed information about Nephrogen investors is not currently available in our database.

What are Nephrogen's future plans?

Future Plans Information Not Available

Detailed information about Nephrogen's future plans and strategic initiatives is not currently available in our database.

What are the latest news about Nephrogen?

No Recent News Available

There are currently no recent news updates available for Nephrogen in our database.

Nephrogen FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Nephrogen including information about founders, CEO, funding history, investors, headquarters location, and company details. 8 frequently asked questions covering key information about the company.

Nephrogen Questions & Answers - Company Information

Q1

What is Nephrogen?

Nephrogen is a biotech company developing curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.

Q2

Where is Nephrogen headquartered?

Nephrogen is headquartered in New York, United States.

Q3

When was Nephrogen founded?

Nephrogen was founded in 2022.

Q4

How many employees does Nephrogen have?

Nephrogen has 1-10 employees.

Q5

What is Nephrogen's official website?

You can visit Nephrogen's official website at http://nephrogenbiotech.com.

Q6

What was Nephrogen's latest funding round?

Nephrogen's latest funding round was a Non equity assistance round completed on 2020-10-01.

Q7

What does the company do?

Nephrogen is a biotech company developing curative gene therapies for kidney diseases.

Q8

Latest funding date?

2020-10-01

More Information About Nephrogen

For additional details about Nephrogen, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.